Cite
HARVARD Citation
Lionel, F. et al. (n.d.). 1435PBevacizumab as first-line treatment in advanced non-squamous non-small cell lung cancer (NSCLC) in patients aged over 65 years in France: Final results of the AVANTAGE study. Annals of oncology. p. . [Online].